Molecular Therapy: Oncology Pharmacology (medical)
Oncolytic virotherapy with chimeric rVSV-NDV causes tumor-specific immunity in a DC-activation-dependent manner
The publisher did not provide an abstract — full text is available via the link below.
Molecular Therapy: Oncology Pharmacology (medical)
The publisher did not provide an abstract — full text is available via the link below.